Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study.

Orandi BJ, Luo X, King EA, Garonzik-Wang JM, Bae S, Montgomery RA, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Osama Gaber A, Segev DL.

Am J Transplant. 2018 Mar;18(3):650-658. doi: 10.1111/ajt.14472. Epub 2017 Sep 23.

2.

The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.

Axelrod D, Lentine KL, Schnitzler MA, Luo X, Xiao H, Orandi BJ, Massie A, Garonzik-Wang J, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Osama Gaber A, Montgomery RA, Segev DL.

Am J Transplant. 2017 Dec;17(12):3123-3130. doi: 10.1111/ajt.14392. Epub 2017 Jul 21.

3.

Quantifying renal allograft loss following early antibody-mediated rejection.

Orandi BJ, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang JM, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL.

Am J Transplant. 2015 Feb;15(2):489-98. doi: 10.1111/ajt.12982. Epub 2015 Jan 21.

4.

Quantifying the risk of incompatible kidney transplantation: a multicenter study.

Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL.

Am J Transplant. 2014 Jul;14(7):1573-80. doi: 10.1111/ajt.12786. Epub 2014 Jun 9.

5.

Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.

Al Meshari K, Pall A, Chaballout A, El Gamal H, Al Mana H, Humaidan H, Alzayer F, Al Talhi M.

Transplant Proc. 2013 May;45(4):1423-6. doi: 10.1016/j.transproceed.2013.01.081.

PMID:
23726587
6.

Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.

Lentine KL, Axelrod D, Klein C, Simpkins C, Xiao H, Schnitzler MA, Tuttle-Newhall JE, Dharnidharka VR, Brennan DC, Segev DL.

Transplantation. 2014 Jul 15;98(1):54-65. doi: 10.1097/TP.0000000000000029. Review.

7.

A single-center analysis of early readmission after renal transplantation.

Kim SH, Baird GL, Bayliss G, Merhi B, Osband A, Gohh R, Morrissey PE.

Clin Transplant. 2019 May;33(5):e13520. doi: 10.1111/ctr.13520. Epub 2019 Mar 27.

PMID:
30861203
8.

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.

Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL.

N Engl J Med. 2016 Mar 10;374(10):940-50. doi: 10.1056/NEJMoa1508380.

9.

Outcomes of ABO-incompatible kidney transplantation in the United States.

Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL.

Transplantation. 2012 Mar 27;93(6):603-9. doi: 10.1097/TP.0b013e318245b2af.

10.

The role of minority geographic distribution in waiting time for deceased donor kidney transplantation.

Vranic GM, Ma JZ, Keith DS.

Am J Transplant. 2014 Nov;14(11):2526-34. doi: 10.1111/ajt.12860. Epub 2014 Aug 25.

11.

Sequelae of early hospital readmission after kidney transplantation.

McAdams-Demarco MA, Grams ME, King E, Desai NM, Segev DL.

Am J Transplant. 2014 Feb;14(2):397-403. doi: 10.1111/ajt.12563. Epub 2014 Jan 21.

12.

Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors.

King EA, Kucirka LM, McAdams-DeMarco MA, Massie AB, Al Ammary F, Ahmed R, Grams ME, Segev DL.

Am J Transplant. 2016 Feb;16(2):541-9. doi: 10.1111/ajt.13485. Epub 2015 Oct 16.

13.

Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.

Cohen JB, Eddinger KC, Locke JE, Forde KA, Reese PP, Sawinski DL.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):974-982. doi: 10.2215/CJN.10280916. Epub 2017 May 25.

14.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

15.

An economic assessment of contemporary kidney transplant practice.

Axelrod DA, Schnitzler MA, Xiao H, Irish W, Tuttle-Newhall E, Chang SH, Kasiske BL, Alhamad T, Lentine KL.

Am J Transplant. 2018 May;18(5):1168-1176. doi: 10.1111/ajt.14702. Epub 2018 Mar 31.

16.

Transplanting the Untransplantable.

Holscher CM, Jackson KR, Segev DL.

Am J Kidney Dis. 2019 Jun 26. pii: S0272-6386(19)30770-X. doi: 10.1053/j.ajkd.2019.04.025. [Epub ahead of print]

PMID:
31255336
17.

Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.

de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ.

Kidney Int. 2005 Feb;67(2):714-20.

18.

Hospital utilization and consequences of readmissions after liver transplantation.

Paterno F, Wilson GC, Wima K, Quillin RC 3rd, Abbott DE, Cuffy MC, Diwan TS, Kaiser T, Woodle ES, Shah SA.

Surgery. 2014 Oct;156(4):871-8. doi: 10.1016/j.surg.2014.06.018.

PMID:
25239337
19.

Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.

Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B.

Transplantation. 2015 Feb;99(2):400-4. doi: 10.1097/TP.0000000000000312.

PMID:
25050471
20.

Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.

Manook M, Koeser L, Ahmed Z, Robb M, Johnson R, Shaw O, Kessaris N, Dorling A, Mamode N.

Lancet. 2017 Feb 18;389(10070):727-734. doi: 10.1016/S0140-6736(16)31595-1. Epub 2017 Jan 6. Erratum in: Lancet. 2017 Feb 18;389(10070):700.

PMID:
28065559

Supplemental Content

Support Center